Transcriptomics

Dataset Information

0

DUSP6 inhibition overcomes Neuregulin/HER3-driven therapy resistance in HER2+ breast cancer

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Homo sapiens

PROVIDER: GSE231526 | GEO | 2024/04/12

REPOSITORIES: GEO

Json Xml

Similar Datasets

Unknown DUSP6 inhibition overcomes Neuregulin/HER3-driven therapy tolerance in HER2+ breast cancer
| S-SCDT-10_1038-S44321-024-00088-0 | biostudies-other
Transcriptomics DUSP6 inhibition overcomes Neuregulin/HER3-driven therapy resistance in HER2+ breast cancer [BT474]
2024-04-13 | GSE231525 | GEO
Transcriptomics DUSP6 inhibition overcomes Neuregulin/HER3-driven therapy resistance in HER2+ breast cancer [MDA]
2024-04-13 | GSE231524 | GEO
Unknown PP2A inhibition overcomes acquired resistance to HER2 targeted therapy.
| S-EPMC4230643 | biostudies-literature
Unknown An antibody that locks HER3 in the inactive conformation inhibits tumor growth driven by HER2 or neuregulin.
| S-EPMC3924863 | biostudies-literature
Unknown Novel Peptidomimetics for Inhibition of HER2:HER3 Heterodimerization in HER2-Positive Breast Cancer.
| S-EPMC4408264 | biostudies-literature
Unknown Neuregulin autocrine signaling promotes self-renewal of breast tumor-initiating cells by triggering HER2/HER3 activation.
| S-EPMC3917843 | biostudies-literature
Unknown Inhibition of the transcriptional kinase CDK7 overcomes therapeutic resistance in HER2-positive breast cancers.
| S-EPMC6937212 | biostudies-literature
Unknown Neratinib overcomes trastuzumab resistance in HER2 amplified breast cancer.
| S-EPMC3858548 | biostudies-literature
Unknown A recombinant human protein targeting HER2 overcomes drug resistance in HER2-positive breast cancer.
| S-EPMC6409101 | biostudies-literature